A Single‐Atom Nanozyme Cascade for Selective Tumor‐Microenvironment‐Responsive Nanocatalytic Therapy

Rasmi Morajkar,Adarsh P. Fatrekar,Amit Vernekar
DOI: https://doi.org/10.1002/cmdc.202200585
IF: 3.54
2023-02-22
ChemMedChem
Abstract:Nanomedicinal research holds significant potential in the development of new cancer therapeutics. Nanozymes can be promising anticancer agents due to their tunable enzyme‐like properties. This highlight features a recently reported bioinspired construction of a cobalt single‐atom nanozyme (Co‐SAs@NC) exhibiting dual enzymatic cascade catalysis for selective reactive oxygen species (ROS)‐induced antitumor activity in the tumor microenvironment. The evolution of cancers to resist existing therapeutic strategies has constantly led researchers to design next‐generation therapeutics. Research on nanomedicine holds significant potential in developing newer cancer therapeutics. Nanozymes bearing the properties of enzymes can be promising anticancer agents due to their tunable enzyme‐like properties. In one such approach, a biocompatible cobalt‐single‐atom nanozyme (Co‐SAs@NC) bearing catalase and oxidase‐like activities that function in cascade at the tumor microenvironment has been reported recently. The current highlight discusses this investigation to unveil Co‐SAs@NC's mechanism in tumor cell apoptosis through in vivo studies.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?